Wells Fargo
EVH icon

Wells Fargo’s Evolent Health EVH Stock Holding History

Wells Fargo’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9,300
Closed -$196K – 7092
2021
Q2 		$196K Buy
+9,300
New +$186K ﹤0.01% 5041

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Wells Fargo's EVH Position: Q2 2026 in Review

Wells Fargo increased its Evolent Health (EVH) stake by 115% in Q2 2026, buying an estimated $223K and bringing the position to 108,973 shares worth $591K. The position accounts for ﹤0.01% of the portfolio, ranked #4502.

Wells Fargo first reported a position in EVH in Q2 2015 and has held it in 45 quarters since. The position peaked at $20.5M in Q2 2016. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Wells Fargo held 108,973 shares of Evolent Health worth $591K as of Q2 2026.
  • Wells Fargo bought 58,273 Evolent Health shares in Q2 2026, an estimated $223K.
  • Evolent Health made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4502 holding.
  • Wells Fargo first reported a position in Evolent Health in Q2 2015 and has held it in 45 quarters since.
  • Wells Fargo's Evolent Health position peaked at $20.5M in Q2 2016.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.